津普森 |
B210134-25g |
25g |
现货 |
29094-61-9 |
N-(4-(N-(环己基氨基甲酰基)氨磺酰基)苯乙基)-... |
99%,B |
456.80
456.80
|
|
津普森 |
B210134-5g |
5g |
现货 |
29094-61-9 |
N-(4-(N-(环己基氨基甲酰基)氨磺酰基)苯乙基)-... |
99%,B |
149.70
149.70
|
|
罗恩 |
R024908-1g |
1g |
5~7个工作日 |
29094-61-9 |
格列吡嗪 Glipizide |
98% |
67.00
67.00
|
|
罗恩 |
R024908-5g |
5g |
5~7个工作日 |
29094-61-9 |
格列吡嗪 Glipizide |
98% |
198.00
198.00
|
|
罗恩 |
R024908-25g |
25g |
5~7个工作日 |
29094-61-9 |
格列吡嗪 Glipizide |
98% |
648.00
648.00
|
|
Selleck |
S171550mg |
50mg |
现货 |
29094-61-9 |
Glipizide |
|
808.92
808.92
|
|
毕得 |
BD132082-25mg |
25mg |
现货 |
29094-61-9 |
N-(4-(N-(环己基氨基甲酰基)氨磺酰基)苯乙基)-... N-(4-(N-(Cyclohexylcarbamoyl... |
99% |
33.00
33.00
|
|
毕得 |
BD132082-250mg |
250mg |
现货 |
29094-61-9 |
N-(4-(N-(环己基氨基甲酰基)氨磺酰基)苯乙基)-... N-(4-(N-(Cyclohexylcarbamoyl... |
99% |
51.00
51.00
|
|
毕得 |
BD132082-1g |
1g |
现货 |
29094-61-9 |
N-(4-(N-(环己基氨基甲酰基)氨磺酰基)苯乙基)-... N-(4-(N-(Cyclohexylcarbamoyl... |
99% |
62.00
62.00
|
|
毕得 |
BD132082-5g |
5g |
现货 |
29094-61-9 |
N-(4-(N-(环己基氨基甲酰基)氨磺酰基)苯乙基)-... N-(4-(N-(Cyclohexylcarbamoyl... |
99% |
189.00
189.00
|
|
阿拉丁 |
G129980-1g |
1g |
现货 |
29094-61-9 |
格列甲嗪 Glipizide |
Moligand™, ≥98% |
55.90
55.90
|
|
阿拉丁 |
G129980-5g |
5g |
现货 |
29094-61-9 |
格列甲嗪 Glipizide |
Moligand™, ≥98% |
164.90
164.90
|
|
阿拉丁 |
G129980-25g |
25g |
现货 |
29094-61-9 |
格列甲嗪 Glipizide |
Moligand™, ≥98% |
539.90
539.90
|
|
阿拉丁 |
G129980-100g |
100g |
现货 |
29094-61-9 |
格列甲嗪 Glipizide |
Moligand™, ≥98% |
1,675.90
1,675.90
|
|
阿拉丁 |
G408514-1ml |
1ml |
现货 |
29094-61-9 |
格列甲嗪 Glipizide |
Moligand™, 10mM in DMSO |
455.90
455.90
|
|
麦克林 |
S838203-5g |
5g |
现货 |
29094-61-9 |
格列吡嗪 Samarium(III) Ionophore I |
|
165.00
165.00
|
|
麦克林 |
S838203-1g |
1g |
现货 |
29094-61-9 |
格列吡嗪 Samarium(III) Ionophore I |
|
56.00
56.00
|
|
TM |
71562-10mg |
10mg |
现货 |
29094-61-9 |
标准品/格列甲嗪 |
≥98.0% |
140.00
140.00
|
|
TM |
71562 |
100mg |
现货 |
29094-61-9 |
标准品/格列甲嗪 |
≥98.0% |
800.00
800.00
|
|
TM |
91963a |
1mL |
现货 |
29094-61-9 |
标准品/甲醇中格列吡嗪 |
1000μg/mL |
300.00
300.00
|
|